ROVI.MC: Laboratorios Farmaceuticos Rovi, S.A. Stock Live Price Graph
About the company
Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical company that focuses on researching, developing, manufacturing, and commercializing medicinal products. Its operations span Spain, the European Union, OECD nations, and global markets. The company also markets certain products under license from other manufacturers. Its primary pharmaceutical portfolio includes Hibor and Enoxaparin biosimilar Becat, both low-molecular-weight heparins for preventing and treating venous thromboembolic conditions. Neparvis targets symptomatic chronic heart failure with reduced ejection in adult patients. For managing hypercholesterolemia, Rovi offers Absorcol, Vytorin, and Orvatez. Respiratory diseases like chronic obstructive pulmonary disease are treated with long-acting bronchodilators Hirobriz Breezhaler and Ulunar Breezhaler. Volutsa is available for men with benign prostatic hyperplasia (BPH) experiencing moderate to severe storage and voiding symptoms who have not adequately responded to monotherapy. Additionally, Medikinet and Medicebrán are used for attention deficit hyperactivity disorder (ADHD) in pediatric and adolescent patients. Beyond pharmaceuticals, Rovi provides various hospital solutions for diagnostic imaging. These include contrast agents like Iomeron and Iopamiro for CT scans and interventions, Multihance and Prohance for MRI, and Sonovue for ultrasounds. It also supplies contrast injection systems such as EmpowerCTA+, EmpowerMR, and CT Exprès, along with compatible disposable materials. The company's offerings extend to over-the-counter pharmaceuticals and contract manufacturing services for other firms, producing a range of dosage forms like prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. Rovi serves a broad client base, including pharmaceutical wholesalers, medical professionals, nurses, pharmacists, and individual patients. Notably, Rovi has partnered with Moderna, Inc. for the production of an mRNA COVID-19 vaccine candidate. Established in 1946, the company is headquartered in Madrid, Spain, and operates as a subsidiary of Norbel Inversiones, S.L.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $0.958 | $0.958 | 1.65% | - |
| - | $0.9351 | $0.9351 | 1.71% | - |
| - | $1.1037 | $1.1037 | 1.30% | - |
| - | $1.2938 | $1.2938 | 3.13% | - |
| - | $0.9556 | $0.9556 | 1.68% | - |
| - | $0.3812 | $0.3812 | 0.66% | - |
| - | $0.1751 | $0.1751 | 0.47% | - |
| - | $0.0798 | $0.0798 | 0.39% | - |
| - | $0.1207 | $0.1207 | 0.76% | - |
| - | $0.183 | $0.183 | 1.06% | - |
| - | $0.1366 | $0.1366 | 1.97% | - |
| - | $0.1269 | $0.1269 | 2.45% | - |
| - | $0.1721 | $0.1721 | 3.08% | - |
| - | $0.141 | $0.141 | 3.02% | - |
| - | $0.0865 | $0.0865 | 2.47% | - |
| - | $0.0783 | $0.0783 | 0.95% | - |
What Is ROVI.MC? Live ROVI.MC Prices and Analysis
ROVI.MC, listed on the Madrid Stock Exchange, is a prominent player in the biotechnology sector, primarily engaged in the development of therapeutic solutions for various diseases. The company focuses on innovative drug development, particularly in the fields of oncology and rare diseases. Investors closely monitor ROVI.MC due to its strategic importance in the healthcare market and its influence on the biotechnology sector in Spain.
As the global demand for advanced medical treatments continues to rise, ROVI.MC’s role in providing effective solutions makes it a significant entity for investors seeking exposure to the biotech industry. The company's performance is often indicative of broader trends in healthcare investment, making it a focal point for both institutional and retail investors.
Market Context
The biotechnology sector is characterized by rapid innovation and significant volatility, influenced by regulatory changes, research breakthroughs, and market sentiment. ROVI.MC operates within this dynamic environment, where international trading and pricing currencies can significantly impact its stock performance. The company is affected by the fluctuations in the euro and the global market trends that define investor confidence in biotech stocks.
Why Do ROVI.MC Prices Rise or Fall?
The stock price of ROVI.MC can be influenced by various factors that investors should consider before making decisions. Understanding these elements can provide insights into market movements and potential investment opportunities.
- Clinical trial results: Positive or negative outcomes can greatly affect stock prices.
- Regulatory approvals: Securing approvals from health authorities can lead to price surges.
- Market competition: New entrants or advancements by competitors can impact ROVI.MC's market position.
- Financial performance: Quarterly earnings reports and guidance can sway investor sentiment.
- Partnerships and collaborations: Strategic alliances can enhance growth prospects.
- Investor sentiment: Overall market conditions and investor mood can influence stock dynamics.
- Technological advancements: Innovations in drug development can create new opportunities.
- Economic conditions: Macroeconomic factors can impact funding and investment in biotech.
Overall, understanding these factors can provide a clearer picture of why ROVI.MC prices may fluctuate, allowing investors to make informed decisions.
Why Is Live ROVI.MC Price Tracking Important?
Tracking the live price of ROVI.MC is essential for investors looking to capitalize on market movements and make timely decisions. Real-time data provides insights into the stock's performance and market trends.
- Informed trading: Access to live prices enables investors to buy or sell at the optimal time.
- Market sentiment analysis: Observing price movements can indicate investor confidence.
- Risk management: Real-time updates help in assessing risks and adjusting portfolios accordingly.
- Investment strategy: Live tracking allows for the fine-tuning of investment strategies based on current data.
- Identifying trends: Investors can spot patterns in price movements that may inform future decisions.
What Should You Consider When Trading / Investing in ROVI.MC?
Investing in ROVI.MC comes with inherent risks and considerations that potential investors should evaluate. Understanding these factors can help mitigate risks and enhance investment outcomes.
- Volatility: The biotech sector can be highly volatile, leading to significant price swings.
- Regulatory risks: Changes in regulations can impact the company's operations and profitability.
- Financial health: Analyze the company's financial statements and earnings reports for insights.
- Market conditions: Broader economic factors can influence stock performance.
- Research and development pipeline: Evaluate the potential of upcoming products and trials.
- Diversification: Consider how ROVI.MC fits into your overall investment strategy.
What Can You Find on the Investvio ROVI.MC Page?
- Live price updates: Real-time stock price information for ROVI.MC.
- Charts and technical analysis: Visual data to understand price trends and patterns.
- News and updates: Latest developments affecting ROVI.MC and the biotechnology sector.
- Company financials: Detailed financial information and performance metrics.
- Market sentiment indicators: Insights into investor confidence and market trends.
In conclusion, ROVI.MC represents a significant opportunity for investors interested in the biotechnology sector. By monitoring live prices and understanding key market dynamics, investors can make informed decisions and position themselves advantageously within the market. For comprehensive information and real-time updates, visit the Investvio ROVI.MC page.